12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

4CIS PEEK, PLIF AND TLIF CAGE SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

Bosworth TruRepair

FDA UDI
Harry J Bosworth Company·H6680921621·3 oz Repair Pwd, Vein

NA

FDA UDI
STERILMED, INC.·10888551021302·BUR DIAMOND ROUND

STRYKER PLATING SYSTEM BASIC FRAGMENT SET

FDA 510(k)
FDA Class 2 ·Orthopedic

STRYKER T4 URETHANE HOOD; STRYKER T4 URETHANE ZIPPER TOGA; STRYKER T4 URETHANE PULLOVER TOGA

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·April 18, 2025

SPECTRA WAVEWRITER

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·April 10, 2020

*

FDA Adverse Event
Malfunction ·OLYMPUS CORPORATION OF THE AMERICAS·Product code FGB·April 8, 2014

MORPHEUS SMART PICC

FDA Adverse Event
Injury ·ANGIODYNAMICS·Product code LJS·April 30, 2013

PULSE GEN MODEL 103

FDA Adverse Event
Malfunction ·CYBERONICS, INC.·Product code LYJ·April 27, 2011

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024